DAWN AC Newsletters – 2017

May 2017

FREE Online Training Resources
Access the DAWN AC User and Safety Manual
New Point of Care interfaces
DAWN INR Capture for self-testing
25th Annual DAWN AC UK User Group
11th DAWN AC North American User Group
Expand your capabilities with DAWN
REVEAL-AF: Silent AF Common in Patients at Risk for AF, Stroke
ORBIT Score Pinpoints Repeat GI Bleeds with Anticoagulation
Aspirin not an effective treatment for atrial fibrillation, study suggests

April 2017

DAWN support desk closures
Work Smarter: DAWN Version 7.9.66
25th Annual DAWN AC UK User Group
Post clinic checklist to enhance patient safety
Front Screen Tallies: Key patient information and checking your DAWN system is working smoothly
Expand your capabilities with DAWN
Patient’s Blood Thinner History Critical to Emergency Medical Services Triage
Artificial intelligence increases adherence to anticoagulation therapy
Praxbind earns new UK status as antidote to Pradaxa

March 2017

NOW AVAILABLE – Edoxaban Module for DAWN AC
24th Annual DAWN AC UK User Group – Proceedings Document
Come and visit us at the North American AC Forum
25th Annual DAWN AC UK User Group
Introducing My Inhealthcare, a new smartphone app for patient self-testing
Expand your capabilities with DAWN
Resuming Oral Anticoagulation Benefits Even After Lobar ICH
Most atrial fibrillation patients don’t get preventive drug before stroke
Some blood thinners may increase heart attack risk

February 2017 

Come and visit us at the North American AC Forum
25th Annual DAWN AC UK User Group
Apixaban & Edoxaban Modules for DAWN AC
Resetting your DAWN password – help and guidance
New way to keep up to date and connect with 4S DAWN
Few Outcomes Differences Seen for Reduced-Dose NOACs in AFib
Stroke Risk Lower for Paroxysmal vs Persistent or Permanent AF: ENGAGE AF-TIMI 48
ACC guidance on periprocedural anticoagulation in A-fib falls short

January 2017

Work Smarter – DAWN Version 7.9.61
DAWN AC North American User Group Proceedings Document
Customer Support Resources
Expand your capabilities with DAWN
Oral Anticoagulant Betrixaban Wins Priority Review
Atrial fibrillation patients more likely to discontinue anticoagulant therapy after procedure, research finds
American College of Cardiology Issues Decision-Making Guide for Periprocedural Management of Anticoagulation in Nonvalvular Atrial Fibrillation